Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Cash from Investing Activities

Amneal Pharmaceuticals Inc Cash from Investing Activities Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Cash from Investing Activities from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Cash from Investing Activities for the quarter ending December 12, 2018 was $5m a 466.45% increase of 25m year over year
  • Amneal Pharmaceuticals Inc Cash from Investing Activities for the last 12 months ending December 12, 2018 was $-396m a 78.18% decrease of -310m year over year
  • Amneal Pharmaceuticals Inc Annual Cash from Investing Activities for 2018 was $-396m a 76.85% decrease of -305m from 2017
  • Amneal Pharmaceuticals Inc Annual Cash from Investing Activities for 2017 was $-92m a -42.64% increase of 39m from 2016
  • Amneal Pharmaceuticals Inc Annual Cash from Investing Activities for 2016 was $-131m a -3.63% increase of 5m from 2015
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Cash from Investing Activities Data

12/2018$5m
09/2018$-41m
06/2018$-341m
03/2018$-19m
12/2017$-11m
09/2017$-35m
06/2017$-30m
03/2017$-25m
12/2016$-36m

Annual AMRX Cash from Investing Activities Data

2018$-396m
2017$-92m
2016$-131m
2015$-136m
2014$-121m